Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
Corticosteroids Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2021 18 8
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Epigallocatechin Gallate Potential treatment - pre-clinical evidence Natural product Antiviral Apr/08/2021 11 0
H014 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/29/2021 3 0
P17 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/29/2021 3 0
FC05 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/29/2021 2 0
HB27 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/29/2021 2 0
Famotidine Potential treatment - clinical evidence Used to treat other disease Unknown Mar/08/2021 2 3
Breast milk Potential treatment - pre-clinical evidence Natural product Antiviral Mar/01/2021 4 0
Excel (.xslx) CSV (.csv)